Getinge (GETI B.ST) Azione Prezzo
Getinge Prezzo
Il fatturato è cresciuto a un tasso composto del 5,3% annuo negli ultimi 19 anni, raggiungendo 34,97 miliardi SEK. L'utile per azione è cresciuto del 3,1% all'anno negli ultimi 19 anni. Il margine netto di Getinge si attesta al 6,5%, in calo rispetto al 11,0% di alcuni anni fa. Getinge offre attualmente un rendimento da dividendo di circa il 1,84%. Il payout ratio è pari a circa il 55% degli utili. Il dividendo è cresciuto del 4,7% all'anno negli ultimi 19 anni. Gli analisti fissano un target di prezzo mediano di 231,03 SEK, ovvero il 7,4% sotto il prezzo attuale. Su 14 analisti, 8 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Getinge Prezzo delle azioni
Getinge Azione e analisi azionaria
Domande frequenti sull'azione Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Gli analisti fissano attualmente un prezzo obiettivo medio di 238,81 SEK per l’azione Getinge (mediana: 231,03 SEK), pari a -4,3 % rispetto all’ultimo prezzo. Il consenso si basa su 14 giudizi di analisti.
14 analisti valutano attualmente l’azione Getinge: 8 raccomandano l’acquisto, 5 la tenuta e 1 la vendita. Per il 2026 gli analisti si aspettano per Getinge ricavi pari a 35,26 miliardi SEK e un utile per azione di 12,89 SEK.
Convertita al tasso di cambio attuale, l’azione Getinge quota 22,31 EUR (249,60 SEK).
L’azione Getinge (GETI B.ST) è quotata su 9 borse, tra cui: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
Il attesa fatturato di Getinge ammonta a 35,26 miliardi SEK. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Getinge ammonta a 3,51 miliardi SEK. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Getinge è attualmente 19,37. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Getinge.
Il rapporto prezzo/fatturato (P/S) di Getinge è attualmente 1,93. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Getinge.
Il Quality Score AlleAktien per Getinge è 4/10.
L'ISIN di Getinge è SE0000202624. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Getinge è 889714. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Getinge è GETI B.ST. Con questo simbolo di borsa vengono negoziate le azioni Getinge in borsa.
Azione Getinge
Gruppo di pari di Getinge
Getinge Ticker
Getinge FIGI
Altre metriche e analisi di Getinge in Deep Dive.
La nostra analisi azionaria dell'azione Getinge include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Getinge. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: